Completed

A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

I5B-MC-JGDN - ClinicalTrials.gov - NCT02677116

The main purpose of this study is to evaluate the safety of different doses of olaratumab and to determine which dose should be used for future pediatric studies. The present study is open to children with advanced cancer or cancer that has spread to another part of the body. The study has two parts. In each part, a specific dose of olaratumab will be given alone for 21 days and followed by one of three standard chemotherapy regimens. Participants will enroll in one part only.
How long will I be in the trial?
Your participation could last up to 3 years depending on how you and your tumor respond.
Email
Completed

A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

I5B-MC-JGDN - ClinicalTrials.gov - NCT02677116

The main purpose of this study is to evaluate the safety of different doses of olaratumab and to determine which dose should be used for future pediatric studies. The present study is open to children with advanced cancer or cancer that has spread to another part of the body. The study has two parts. In each part, a specific dose of olaratumab will be given alone for 21 days and followed by one of three standard chemotherapy regimens. Participants will enroll in one part only.
How long will I be in the trial?
Your participation could last up to 3 years depending on how you and your tumor respond.
Email

Key Requirements

Age :

< 17

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

< 17

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Pediatric Neoplasm Metastasis

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

79

Trial Dates

August 2016 - April 2019

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

< 17

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Pediatric Neoplasm Metastasis

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

79

Trial Dates

August 2016 - April 2019

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Pediatric Neoplasm Metastasis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?